Circulating tumor cells (CTCs) are cells that have shed into the vasculature from a primary tumor and circulate in the bloodstream. CTCs thus constitute seeds for subsequent growth of additional tumors (metastasis) in vital distant organs, triggering a mechanism that is responsible for the vast majority of cancer-related deaths. CTCs were observed for the first time in 1869 in the blood of a man with metastatic cancer by Thomas Ashworth, who postulated that “cells identical with those of the cancer itself being seen in the blood may tend to throw some light upon the mode of origin of multiple tumours existing in the same person”.
This report on Circulating Tumor Cells (CTC) Technologies gives a market insight into technologies and services used for cancer detection. The market is analyzed by Cancer type into Prostate, Breast and Other; and by Function into Prognostics, Diagnostics and Therapy Management. The report serves as a guide to CTC industry, covering more than 190 companies that are engaged in CTC studies/screening, products and services. Major Contract Research Organizations, Research Institutes and Universities serving the CTC market are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to CTC Technologies is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, and Asia-Pacific with 40 exclusive graphically represented exhibits.
Global CTC Technologies market is predicted to increase at a CAGR of 25.91% for the analysis period 2010-2020. Cancer is a growing scourge as about 11 million people are being diagnosed with cancer every year and estimates say that are likely to be about 16 million new cases every year by 2020. Johnson & Johnson, through its Veridex LLC division, is the only company with FDA approval in the CTC Technologies area. The CellSearch's CTC test kit is valuable in assessing the prognosis of patients suffering from metastatic stage in breast cancer, prostate cancer and colorectal cancer. Several companies throughout the world have products in clinical trials and are expected to compete vigorously in the next few years with improvised products.
Report by Chapter
- Scope and Methodology: This chapter provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used.
- Report Synopsis: Synopsis of the report summarizes the global Circulating Tumor Cells (CTC) Technologies market, by Cancer Type and Function Type. Global market is also analyzed by geographic regions including North America, Europe, Asia-Pacific and Rest of World. The chapter provides market values (2010 - 2020) in US$ for each geographic region. A List of major Global companies is also provided.
- Market Dynamics: Market Dynamics chapter provides information on global markets for Circulating Tumor Cells (CTC) Technologies. The chapter includes global market analysis (in US$) by geographic region; analysis of each region by both Cancer type and Function type; a brief business profile of (59) major global companies; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches, etc. The section includes key market trends and an industry outlook.
- Product/Technology Research: This chapter gives an insight into Circulating Tumor Cells (CTC) Technologies market including definitions, segmentation and applications. The chapter also includes product trends and potential opportunities. Various CTC detection methods, and the challenges faced by the industry are also discussed. Various research activities in the field of CTC Technologies finds a mention in this chapter.
- Corporate Directory: This chapter provides a global region-wise list of 150 plus companies, CROs, hospitals and academic institutions that offer Circulating Tumor Cells (CTC) Technologies products and/or services
- Patents Information: This chapter provides a compilation of worldwide patents related to Circulating Tumor Cells (CTC) Technologies.
Report Highlights
Global CTC Technologies market is predicted to increase at a CAGR of 25.91% for the analysis period 2010-2020. Cancer is a growing scourge as about 11 million people are being diagnosed with cancer every year and estimates say that are likely to be about 16 million new cases every year by 2020. Johnson & Johnson, through its Veridex LLC division, is the only company with FDA approval in the CTC Technologies area. The CellSearch's CTC test kit is valuable in assessing the prognosis of patients suffering from metastatic stage in breast cancer, prostate cancer and colorectal cancer. Several companies throughout the world have products in clinical trials and are expected to compete vigorously in the next few years with improvised products.
Why Buy This Report?
This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –
Global CTC Technologies market is predicted to increase at a CAGR of 25.91% for the analysis period 2010-2020. Cancer is a growing scourge as about 11 million people are being diagnosed with cancer every year and estimates say that are likely to be about 16 million new cases every year by 2020. Johnson & Johnson, through its Veridex LLC division, is the only company with FDA approval in the CTC Technologies area. The CellSearch's CTC test kit is valuable in assessing the prognosis of patients suffering from metastatic stage in breast cancer, prostate cancer and colorectal cancer. Several companies throughout the world have products in clinical trials and are expected to compete vigorously in the next few years with improvised products.
Why Buy This Report?
This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –
- Identify Market Opportunities
- Review and Analyze Global and Regional Markets
- Gauge Market Potential for your Products
- Identify Competition
- Use Market Research for exploring new areas
- Acquire Meaningful Guidelines for Strategic Planning
- Gear up for Market Entry
Get Actionable Information Analytics and data presented in each report pertain to several parameters such as –
- Global and Regional Market Sizes, Market Shares, Market Trends
- Product (Global and Regional) Market Sizes, Market Shares, Market Trends
- Technology Trends
- Corporate Intelligence
Key Companies By Sales, Brands, Products
Report Link: https://wiseguyreports.com/reports/circulating-tumor-cells-ctc-technologies-market-research-report
- Other Strategic Business Affecting DataCompanies Discussed
- 13+ Circulating Tumor Cells (CTC) Technologies Company Insight Profiles
- 194+ Company Directory Listing
- Abnova Corporation (Taiwan)
- AVIVA BioSciences Corporation (USA)
- BioCep Ltd. (Israel)
- Canopus Bioscience Ltd. (Canada)
- Exelixis, Inc. (USA)
- Fluxion Biosciences, Inc. (USA)
- Ikonisys, Inc. (USA)
- Miltenyi Biotec, Inc. (USA)
- On-Q-ity (USA)
- RareCells SAS (France)
- ScreenCell (France)
- Telo VISION, LLC (USA)
- Veridex, LLC (USA)
Report Link: https://wiseguyreports.com/reports/circulating-tumor-cells-ctc-technologies-market-research-report
No comments:
Post a Comment